AN ACT relating to health insurer contracts with participating providers.
SB311 would regulate how health insurers in Kentucky may change contracts with participating providers. The bill prohibits insurers from altering reimbursement, payment methodology, fee schedules, or claim-adjudication terms through provider manuals, policy updates, or other incorporated documents unless the change is made by a written amendment signed by both parties. It also defines “material change” and sets out procedures for notice, provider response, negotiation, and termination when an insurer proposes changes to an existing provider agreement.
For most material changes, insurers would have to give at least 90 days’ notice and include specific information such as the effective date, description of the change, insurer contact information, and an opportunity for discussion. If the change affects inclusion in new or modified insurance products or network membership, the provider must affirmatively accept it in writing, and notice must be sent by certified mail. For other material changes, the provider may object in writing within 30 days, after which the parties must negotiate for 30 days before unwinding the relationship if no agreement is reached. The bill also requires 15 days’ notice for changes to prior authorization, precertification, notification, referral, or edit programs, and it applies only to contracts entered into or renewed on or after the effective date.
The bill would amend KRS 304.17A-235 and add a new section to KRS Chapter 304 Subtitle 17A, creating enforceable limits on how insurers can modify provider agreements. It would make certain unilateral changes void and unenforceable, require more formal notice and consent procedures, and impose specific communication and mailing requirements for insurers. The practical effect would be to strengthen contractual protections for participating providers and increase administrative obligations for health insurers and managed care plans operating in Kentucky.
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears to be policy-driven and provider-protective, with the bill framed as a consumer- and provider-contract fairness measure. The detailed notice and consent rules suggest an intent to curb insurer practices that providers may view as one-sided or difficult to track. No formal vote record or transcript is available here to show support or opposition, but the structure of the bill indicates it is aimed at addressing provider concerns about surprise contract changes.
The main points of contention are likely to be the bill’s restrictions on insurer flexibility and the administrative burden it places on health plans. Insurers may object to the requirement that certain changes be made only by written amendment, the 90-day notice period, the mandatory negotiation window, and the special mailing and formatting rules, including the orange envelope requirement. Providers, by contrast, would likely support the bill’s limits on unilateral changes, clearer notice, and the ability to reject or negotiate material changes that affect reimbursement or network participation.